These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8106944)

  • 41. [Use of purified FSH in female infertility].
    Antoine JM; Salat-Baroux J
    Contracept Fertil Sex; 1993 Apr; 21(4):301-6. PubMed ID: 7951630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequential clomiphene citrate-menotropin therapy for induction or enhancement of ovulation.
    Kemmann E; Jones JR
    Fertil Steril; 1983 Jun; 39(6):772-9. PubMed ID: 6406271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovulation induction by human menopausal gonadotropin with ultrasonic monitoring of the ovarian follicles.
    Tulandi T; Hamilton EF; Arronet GH; Coleman PW; McInnes RA
    Int J Fertil; 1987; 32(4):312-5. PubMed ID: 2887531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human gonadotropin therapy. I. Serum estradiol and progesterone patterns during conceptual cycles.
    Bergquist C; Nillius SJ; Wide L
    Fertil Steril; 1983 Jun; 39(6):761-5. PubMed ID: 6406269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Optimal Ovulation Induction in Polycystic Ovary Syndrome Resistant to Clomiphene Citrate or Letrozole.].
    Chen Y; Zhang D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 47(6):874-877. PubMed ID: 28598116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful induction of ovulation and conception with pulsatile intravenous administration of human menopausal gonadotropins in anovulatory infertile women resistant to clomiphene and pulsatile gonadotropin-releasing hormone therapy.
    Ho Yuen B; Pride SM; Sime MO
    Am J Obstet Gynecol; 1984 Mar; 148(5):508-12. PubMed ID: 6422760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of the somatostatin analogue octreotide on ovulatory performance in women with polycystic ovaries.
    Prelevic GM; Ginsburg J; Maletic D; Hardiman P; Okolo S; Balint-Peric L; Thomas M; Orskov H
    Hum Reprod; 1995 Jan; 10(1):28-32. PubMed ID: 7745065
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA; Hall JE; Adams JM; Crowley WF
    J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Menotropins alone are superior to a clomiphene citrate and menotropin combination for superovulation induction among clomiphene citrate failures.
    Ransom MX; Doughman NC; Garcia AJ
    Fertil Steril; 1996 Jun; 65(6):1169-74. PubMed ID: 8641492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A; David H; Libal Y; Ballas S
    Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of outcomes from in vitro fertilization cycles stimulated with either recombinant luteinizing hormone (LH) or human chorionic gonadotropin acting as an LH analogue delivered as human menopausal gonadotropins, in subjects with good or poor ovarian reserve: a retrospective analysis.
    Dahan MH; Agdi M; Shehata F; Son W; Tan SL
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():70-3. PubMed ID: 24314801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of ovarian follicular and luteal function during treatment with exogenous gonadotropins in anovulatory infertility.
    Yuen BH; Sy L; Cannon W
    Am J Obstet Gynecol; 1981 Jul; 140(6):629-35. PubMed ID: 6167169
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
    Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
    Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship among serum levels of luteinizing hormone, estradiol, and progesterone during follicle stimulation and results of in vitro fertilization and embryo transfer (IVF-ET).
    Kagawa T; Yamano S; Nishida S; Murayama S; Aono T
    J Assist Reprod Genet; 1992 Apr; 9(2):106-12. PubMed ID: 1627924
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of pre-ovulatory luteinizing hormone surge by gonadotrophin-releasing hormone agonist for women at risk for developing the ovarian hyperstimulation syndrome.
    Shalev E; Geslevich Y; Ben-Ami M
    Hum Reprod; 1994 Mar; 9(3):417-9. PubMed ID: 8006128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gonadotropin-releasing hormone and its analogues: applications in gynecology.
    Garcia JE
    Clin Obstet Gynecol; 1993 Sep; 36(3):719-26. PubMed ID: 8403618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Controlled hyperstimulation in intra-uterine inseminations: hMG-hCG protocol (204 cycles)].
    Abboud P; Delépine B; Pigeon F; Bednarczyk L; Quéreux C
    Contracept Fertil Sex; 1997 Jun; 25(6):463-9. PubMed ID: 9280551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of hormonal changes during combined buserelin/HMG treatment.
    Urbancsek J; Rabe T; Grunwald K; Kiesel L; Runnebaum B
    Hum Reprod; 1990 Aug; 5(6):675-81. PubMed ID: 2123882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.